FinCanna Capital Corp (CSE:CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed cannabis industry is pleased to announce the appointment of Patrick Goggin, a Senior Attorney at Hoban Law Group (HLG) to its Board of Advisors. HLG is the nation’s premier cannabusiness law firm, serving clients across the country with medical and adult use marijuana businesses as well as those operating in the industrial hemp sector.

Patrick has waged battle on the legal front lines of industrial hemp and general cannabis reform for over two decades. He is based in San Francisco where he served as co-counsel in the seminal HIA v. DEA 2000s cases. In 2005, Patrick helped lead industry efforts for passage of San Francisco’s inaugural ordinance regulating medical cannabis and later served on the city’s Medical Cannabis Task Force. Patrick also led the industry effort with Senator Mark Leno in 2013 to pass California’s Industrial Hemp Farming Act. He sits on Vote Hemp’s board, serves as general counsel for the newly formed California Hemp Council, and is a leader in industry efforts to implement hemp farming and processing in California. Patrick was admitted to the California Bar in 1996 after receiving his J.D. from Lewis and Clark Law School in Portland, Oregon.


“We are delighted to have Patrick join our Advisory Board,” said Andriyko Herchak, CEO of Fincanna Capital. “He is a highly regarded professional, practicing with Hoban Law Group, the foremost full service business-oriented law firm serving the cannabis industry. We are fortunate to have an individual with his depth of knowledge and experience in the legal cannabis industry, join our team. We will, most certainly be drawing on Patrick’s expertise as we continue to build our diversified investment portfolio in creating long term sustainable value for our shareholders.”

Patrick joins FinCanna’s other US Advisory Board members Gaynell Rogers, an authoritative voice in the US medical cannabis sector and a highly regarded media and publicity consultant and Dani Walton, a ten-year veteran at Harborside, who’s expertise includes, changing consumer trends, new brands and products and the evolving science of cannabis medicine. FinCanna’s Canadian based Advisory Board members include, John Campbell, Chairman and CFO of TriView Capital, one of Canada’s largest Exempt Market Dealers and Rosy Mondin, CEO of Quadron Cannatech, is the world’s first woman founder and CEO of a publicly traded company in the cannabis sector.

About Hoban Law Group

Hoban Law Group was the nation’s first, since 2008, full time, full service business-oriented law firm serving the cannabis industry exclusively. Additionally, Hoban Law Group was the first U.S. based law firm to expand its cannabis industry services around the globe. Providing legal counsel in numerous countries to international businesses, governments, and ancillary service providers, Hoban Law Group, created the world’s largest and most sophisticated cannabis industry network. The firm’s current network of strategic global partners includes professional consultants and service providers with expertise in the global hemp marketplace and the regulated marijuana industry. Headquartered in Denver Colorado the firm has offices in a number of US cities. For more information about Hoban Law Group visit https://hoban.law

About FinCanna Capital Corp.

FinCanna is a royalty company that provides growth capital to rapidly emerging private companies operating in the licensed U.S cannabis industry.  The Company earns its revenue from royalties paid by its investee companies that are calculated based on a percentage of their total revenues.

FinCanna’s scalable royalty model provides an attractive alternative or complement to debt or equity financing for its investee companies. FinCanna is focused on delivering high-impact returns to its shareholders by way of a strategically diversified investment portfolio.

For additional information visit www.fincannacapital.com and FinCanna’s profile at www.sedar.com.

FinCanna Capital Corp.
Andriyko Herchak, CEO & Director

Investor Relations:
Arlen Hansen
Kin Communications
1-866-684-6730
CALI@kincommunications.com

Cautionary Note Regarding Forward-Looking Statements
Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about how the developing U.S. legal regime will impact the cannabis industry.  By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the CSE listing statement and other reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Click here to connect with FinCanna Capital Corp (CSE:CALI) for an Investor Presentation. 

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less